Isolated molecular structure, enveloping and combining viruses, vaccine formulation, anti-corporomonoclonal, polyclonal antiserum, jelly, foam, contraceptive cream or ointment, mammal and human blood samples, kit, cell line, treatment processes or prevention of infection by a virus in subject, treatment or prevention of infection by a human infection, inhibition of infection by a virus in a blood sample, inhibition of infection by HIV in a human blood sample, decontamination of surgical or dental tools, monitoring of antibody product to molecular structure, production of an immunogen for use in a vaccine for treatment or prevention of infection by a virus, and production of an immunogen for use in a vaccine for the treatment or prevention of HIV infection, cross-linked structure, monoclonal antibody to the structure , decontamination of surgical or dental tools, pro selection process of a molecular structure for vaccine efficacy, mammal, isolated protein complex, devacin formulation, p

摘要

"ISOLATED MOLECULAR STRUCTURE, COMBINATING ENVELOPER VIRUS, VACCIN FORMULATION, ANTICORPOMONOCLONAL, POLYCLONAL ANTI-SERUM, JELLY, FOAM, CREAM OR CONTRACEPTIVE VEGETABLE, SAMPLING, DEATHING OF MAMOUSING, HUMANEOUS, HUMANEOUS, HUMANEOUS, HUMANEOUS, WOMEN IN A SUBJECT, TREATMENT OR PREVENTION OF PORHIV INFECTION IN A HUMAN, INHIBITION FROM INFECTION BY UMVIRUS IN A BLOOD SAMPLE, INHIBITION FROM HIV INFECTION IN A BLOOD SAMPLE, IN DISTRIBUTION OF HOSPITALIZATION ANTIBODY FOR THE MOLECULAR STRUCTURE, FOR THE PRODUCTION OF AN IMMUNOGENE FOR USE IN A VACCINE FOR THE TREATMENT OR FOR THE PREVENTION OF INFECTION WITH A VIRUS, AND FOR THE PRODUCTION OF A IMMUNOGENE FOR USE IN A VACCINE FOR THE TREATMENT OR THE PREVENTION OF INFECTION, HEALTHY PROTECTION, INFECTION, HEALING FOR STRUCTURE, DECONTAMINATION OF SURGICAL OR DENTAL TOOLS , PROCESS OF SELECTING A MOLECULAR STRUCTURE FOR VACCINE EFFECTIVENESS, MAMPHEROUS, ISOLATED PROTEIN COMPLEX, VACCIN FORMULATION, IMMUNIZATION PROCESSES OF AN ANIMAL FOR A VIRUS, AND PREPARATION OF A COMPLEX, PROTEIN, PURPLE PROTEIN, PROTEIN COMPLEX. , AND TREATMENT OF A HOST WITH HAVING BEEN EXPOSED TO A VIRUS, OR PREVENTION OF INFECTION OF A HOST WITH THE CITIZEN VIRUS, AND, COMPOSITION ". The invention refers to the generation of molecular structures related to fusion (FRMS) that comprise one or more determinants related to transitional mergers. Highly effective vaccines can be built which present the fusion-related determinants for the immune system that engenders unique antibodies capable of potentially neutralizing a wide variety of primary isolates, localizations from around the world and different viral-phylogenetic clades. The present invention provides FRMS formation, isolation and purification processes as well as the use of FRMS detals in a variety of compositions and processes, including for example, as vaccine immunogens, in diagnosis, and in therapy. The present invention relates to RFMS capable of generating neutralizing antibodies to viral pathogens and primary isolates of a virus. Antibodies produced for FRMS can be used to study the molecular route in the fusion direction of the virus and the host cell and to identify points of possible antibody-mediated blocking for the aquelota. The invention also relates to the use of invention antibodies in antiviral agents, blood product additives, passive contraceptive immunization additives in post-exposure treatments or in fetal immunization.